Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glioblastoma | D005909 | EFO_0000515 | — | 2 | 1 | — | — | — | 2 |
Recurrence | D012008 | — | — | 1 | 1 | — | — | — | 1 |
Glioma | D005910 | EFO_0000520 | — | 1 | 1 | — | — | — | 1 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | — | 1 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | — | 1 |
Triple negative breast neoplasms | D064726 | — | — | 1 | 1 | — | — | — | 1 |
Ovarian epithelial carcinoma | D000077216 | — | — | 1 | 1 | — | — | — | 1 |
Drug common name | Pamiparib |
INN | pamiparib |
Description | PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP).
|
Classification | Small molecule |
Drug class | poly-ADP-ribose polymerase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@]12CCCN1CC1=NNC(=O)c3cc(F)cc4[nH]c2c1c34 |
PDB | — |
CAS-ID | 1446261-44-4 |
RxCUI | — |
ChEMBL ID | CHEMBL4112930 |
ChEBI ID | — |
PubChem CID | 135565554 |
DrugBank | DB14769 |
UNII ID | 8375F9S90C (ChemIDplus, GSRS) |